Welcome to another episode of Tort Talk Thursday! In this episode, Susan Barfield connects with Joe Fantini to discuss the latest developments in mass tort litigation. They recap 2024 and look ahead to what's coming in 2025, covering key cases and deadlines. 🔑 Key Moments 📝 ● Talc Litigation Recap [0:26]: Joe discusses the third bankruptcy filing by J&J and the upcoming trial set for February 18th. This trial is crucial to see if third parties can take advantage of the bankruptcy system. ● Roundup Litigation Update [1:23]: They review the significant verdicts in the Roundup cases, including some plaintiff wins with over $6 billion in verdicts, and discuss the potential for the case to reach the Supreme Court on preemption. ● CPAP Settlement [2:17]: Joe explains the surprise global settlement that resolved over 50,000 CPAP cases. ● Upcoming January Deadlines [2:44]: Susan and Joe discuss important deadlines for Depo-Provera, CPAP, Suboxone, and Talc litigations in January. ● Suboxone Litigation [2:58]: Joe details the ruling on the motion to dismiss, where failure to warn and design defect claims survived, and the upcoming case management conference on January 14th. ● CPAP and Zantac Deadlines [2:58]: Joe mentions deadlines at the end of the month for submitting medical records and proof of injuries for both CPAP and Zantac cases. ● Depo-Provera JPML [2:58]: They discuss the motion to consolidate the Depo-Provera cases, with a decision expected at the end of January. ● Paraquat Litigation [4:16]: Joe highlights the heating up of the Paraquat litigation, including a deadline for a defendant's motion for summary judgment on January 7th, and a possible settlement before the first trial in April. ● Bair Hugger Litigation [4:16]: Bellwether trials are scheduled for March 2025, and a settlement is expected. ● Roundup Settlements [4:16]: Joe expresses optimism for firm inventory settlements, though not a global settlement, in 2025. ● Toxic Baby Food Litigation [5:33]: The trial date has been pushed to June, and motions to dismiss in the MDL are being worked up with an argument towards the end of the first quarter. Don't miss these important updates on the world of mass torts! **Make sure to subscribe to the Case Works channel and turn on notifications to stay informed about the latest industry news and updates.** Connect with Joe: https://www.linkedin.com/in/joseph-fantini/ Connect with Case Works: https://www.linkedin.com/company/your-case-works/ See the full transcript here: https://yourcaseworks.com/the-leverage-report/kicking-off-2025-with-upcoming-mass-tort-deadlines-and-the-latest-developments/
Welcome back to another episode of Tort Talk Thursday, or hello if you're new here! 👋🏻 Joe Fantini joins Susan on this week's episode to discuss the latest updates in mass tort litigation, including: ● 01:18 - Bair Hugger MDL - Joe Fantini discusses the Bair Hugger MDL, noting it was formed in 2016 and currently has almost 8,000 filed cases. The first bellwether trials are scheduled to begin in March 2025. ● 01:56 - Ozempic Litigation Updates on the Ozempic litigation reveal there are about 1,300 filed cases in the Eastern District of Pennsylvania. A scheduling order related to the defendant's motion to dismiss has been issued, with a decision expected in early summer 2025. If the motion to dismiss is defeated, the litigation will move forward, with potential trials in 2026. ● 02:56 - Uber litigation, which has approximately 1,500 filed cases. Uber is fighting the consolidated actions, and a decision from the appellate court is pending. The first bellwether trials are expected to begin in the fall of 2025. Sponsored by: https://www.finlegal.io/ Connect with Joe: https://www.linkedin.com/in/joseph-fantini/ Connect with Case Works: https://www.linkedin.com/company/your-case-works/ See the full transcript here: https://yourcaseworks.com/the-leverage-report/bair-hugger-trial-set-ozempic-motion-dismissal-uber-bellwether/
Welcome back to another episode of Tort Talk Thursday, or hello if you're new here! 👋🏻 Joe Fantini joins Susan on this week's episode to discuss the latest updates in mass tort litigation, including: ● 0:30 - Roundup Litigation Update Joe provides an update on the Roundup litigation, including a recent mistrial in Chicago and upcoming trials scheduled for 2024. ● 1:22 - Suboxone Litigation Update Joe discusses the Suboxone litigation, a case that has been "flying under the radar." He notes that oral arguments on a motion to dismiss are scheduled for December 16th. ● 2:17 - Depo Provera: The Main Tort of 2025? Joe highlights the Depo Provera litigation as a potential major case in 2025, with nearly 30 cases already filed. He discusses plans for a JPML consolidation hearing in 2025 and the focus on brain tumor cancers as a signature injury. Connect with Joe: / joseph-fantini Connect with Case Works: / your-case-works See the full transcript here: https://yourcaseworks.com/the-leverag...
Welcome to this week's episode of Tort Talk Thursday Sponsored by Case Legal Media! 👉🏻 Zantac: The first Zantac trial ended in a mistrial in California. Key deadlines are approaching in the Delaware Zantac settlement, including a December 2nd deadline for declarations of use and a January deadline for proof of injury records. 👉🏻 Paraquat: Dispositive and expert motions in the Philadelphia Paraquat litigation were pushed back one month to January 2025. Jury selection remains scheduled for the end of March 2025, with the first trial expected to begin in April 2025. 👉🏻 AFFF: Over 2,000 cases related to class action water provider settlements have been dismissed in the AFFF MDL, leaving approximately 7,500 personal injury cases pending. Fact discovery is expected to conclude in mid-December, followed by expert discovery in the first and second quarters of 2025. Key Moments: * Introduction and Sponsor Recognition: 0:06 - 1:32 * Zantac Update: 1:40 - 2:34 * Paraquat Update: 2:41 - 3:18 * AFFF Update: 3:24 - 4:18 Learn more about this week's sponsor, Case Legal Media here: https://www.caselegalmedia.com/ Get the full transcript here: https://yourcaseworks.com/the-leverage-report/zantac-paraquat-and-afff-case-updates-you-need-to-know/
In this episode of The Leverage Report, Melissa Martinez is joined by experienced mass tort litigators Tara Sutton and Tracy Finken to discuss the Depo-Provera litigation, focusing on the increased risk of meningioma, a type of brain tumor. Whether you are a potential client or a lawyer interested in learning more about the Depo-Provera litigation, this video provides important information about the legal issues and challenges involved. Key Moments: ● Who is being sued? (02:58) ●The importance of gathering medical records. (05:53 - 10:19) ● Statutes of limitations. (10:56 - 14:00) ● Client expectations. (14:24 - 18:13) ● How to stay in touch with your lawyer. (18:13 - 21:09) ● Steps to take if you have a claim. (21:22 - 23:30) Tara Sutton and Tracy Finken are experienced mass tort litigators with a proven track record of success. They are passionate about helping their clients obtain justice and are committed to providing them with the highest quality legal representation. How to get in touch: tfinken@anapolweiss.com tsutton@robinskaplan.com Get the full transcript here: https://yourcaseworks.com/the-leverag... Disclaimer: This video is for informational purposes only and should not be considered legal advice. If you have any legal questions, please consult with a qualified attorney.
Broughton Partners CEO Discusses Strategies for Successful Case Acquisition In this episode of The Leverage Report, Dan Miner, CEO of Case Works, sits down with Cason Carter, CEO and founder of Broughton Partners, to discuss strategies for ensuring successful case acquisition. Key Moments: Introduction: [0:05] Broughton Partners' Approach to Case Acquisition: [0:35] Reducing Fallout Rates: [1:10] The Importance of Branded Caller Display: [2:29] Verifying Treatment Facility and Doctor Information: [3:28] Ensuring Success for Referral Firms: [5:41] Using Data to Make Informed Decisions: [6:54] Challenges in the Industry: [8:39] Connecting with Broughton Partners: [9:28] Cason Carter shares insights on how Broughton Partners reduces fallout rates, leverages data to optimize processes, and partners with law firms to achieve success in mass tort cases. He emphasizes the importance of alignment between all parties involved in the case acquisition process and provides practical tips for improving conversion rates. Subscribe to The Leverage Report for more valuable insights on the legal industry! Get the full transcript here: https://yourcaseworks.com/the-leverage-report/how-a-tech-first-approach-can-revolutionize-mass-tort-case-quality/ Learn more about Broughton Partners here: https://www.broughtonpartners.com/ Get in touch with Case Works here: https://yourcaseworks.com/contact/
Joe Fantini, a mass tort attorney with Rosen Injury Lawyers, joins Susan Barfield on Tort Talk Thursday to discuss his top five mass tort power rankings for 2025. Fantini shares valuable insights for attorneys looking to get involved in mass tort litigation, focusing on mature torts with a strong scientific basis and the potential for significant settlements or jury awards. Key Moments: Introduction and Sponsor Message from Jurist: [0:06] Roundup Litigation: [1:19] Fantini highlights the maturity of the Roundup litigation, noting the billions of dollars already paid in settlements and the numerous trials scheduled. AFFF/PFAS Litigation: [2:22] Fantini discusses the substantial settlements already reached in the AFFF/PFAS class action cases related to water contamination, indicating the defendants' willingness to resolve cases. Hair Relaxer Litigation: [3:17] Fantini explains the scientific support linking hair relaxers to certain types of cancer, the growing number of cases pending in the MDL, and the anticipation of upcoming trials. Paraquat Litigation: [4:03] Despite a recent setback in the MDL, Fantini expresses optimism about the Paraquat litigation, pointing to pending trials in Philadelphia. Depo Provera Litigation: [4:03] Fantini describes the Depo Provera litigation as a promising new mass tort with the potential for substantial case volume due to the severity of alleged injuries. The Philadelphia Factor: [4:59] Fantini acknowledges that the location of trials, particularly in Philadelphia, influences his mass tort rankings. Fantini's insights provide valuable guidance for attorneys seeking to expand their practices into the mass tort arena, emphasizing the importance of thorough research, scientific backing, and strategic case selection. Subscribe to the Case Works channel for more updates and insights on the mass tort industry! Thanks to this week's sponsor - Jurist! Check them out here: https://getjurist.ai/ Connect with Joe: https://www.linkedin.com/in/joseph-fantini/ Connect with Case Works: https://www.linkedin.com/company/your-case-works/ See the full transcript here: https://yourcaseworks.com/the-leverage-report/joe-shares-top-5-mass-torts-to-get-involved-in-going-into-2025/
Joe Fantini and Susan Barfield connect this week to discuss the latest news in the mass tort world. On this week's episode: ⚖️ NEC verdict in favor of the defense ⚖️ Opioid plaintiffs may see settlements soon ⚖️ AFFF lawsuit updates Thanks to this week's sponsor of Tort Talk Thursday, Broughton Partners, https://www.broughtonpartners.com/. Subscribe to our channel to get the first look at the news each week! See the full transcript here: https://yourcaseworks.com/the-leverage-report/nec-defense-verdict-settlements-for-opioid-plaintiffs-afff/
In this insightful episode, Amy Angelo of MTMP and our very own Melissa Martinez dive into the comprehensive paralegal programs offered by MTMP (Mass Torts Made Perfect). They discuss how MTMP supports paralegals with unique opportunities to expand their knowledge, earn industry-recognized certifications, and network with top professionals in the legal field. From specialized courses to certification programs, MTMP’s paralegal offerings are designed to enhance skills, build confidence, and advance careers in mass tort law.
🎓 What You'll Learn:
1. The variety of courses and certifications available through MTMP's paralegal programs
2. How networking with experienced paralegals and attorneys can enhance your career
3. The benefits of industry-specific knowledge tailored to the mass torts field
4. Success stories and insights from MTMP’s growing community of paralegalsWhether you're an experienced paralegal or just starting in the legal field, MTMP’s paralegal programs offer a unique pathway to professional growth. Don’t miss this chance to learn from Amy and Melissa and discover how MTMP can support your journey!
👉 Interested in learning more? Visit MTMP’s Paralegal Programs to get started today!
Full transcript is available on the Case Works website here: https://yourcaseworks.com/the-leverage-report/amy-angelo-mtmp-paralegal-programs/
Joe Fantini and Susan Barfield connect this week to discuss major news in the mass tort world. On this week's episode: ⚖️ J&J Bankruptcy: Trial is being scheduled for late January/early February ⚖️ AFFF: Court enters CMO #31 - Plaintiff Profile Forms ⚖️ Paraquat: Update on cases filed in Philadelphia ⚖️ NEC: Missouri trial and MDL hearings for 2025 Subscribe to our channel to get the first look at the news each week! See the full transcript here: https://yourcaseworks.com/the-leverage-report/major-afff-jj-bankruptcy-paraquat-cases-and-nec-trials/
Welcome back to another episode of Tort Talk Thursday! Where Joe Fantini brings us the weekly news in the world of mass torts. On this week's episode of Tort Talk Thursday, we cover the following: 👉🏻 DOJ files a motion to dismiss J&J bankruptcy for bad faith filing 👉🏻 Consolidation an issue for Uber MDL? 👉🏻 Challenges with Suboxone litigation Thanks to this week's sponsor - Tort Experts! Check them out here: https://www.tortexperts.com/ Connect with Joe: https://www.linkedin.com/in/joseph-fantini/ Connect with Case Works: https://www.linkedin.com/company/your-case-works/ See the full transcript here: https://yourcaseworks.com/the-leverage-report/doj-opposes-jj-bankruptcy-challenges-for-uber-and-suboxone/
Welcome back to another episode of Tort Talk Thursday with Susan Barfield and Joe Fantini! In this episode, Joe shares what he knows about: 👉🏻 Recap of Fall 2024 MTMP Session 👉🏻 What Early Criteria Firms Are Using for Depo-Provera Claims 👉🏻 Zantac Global Settlement Pending Connect with Joe: https://www.linkedin.com/in/joseph-fantini/ Connect with Case Works: https://www.linkedin.com/company/your-case-works/ See the full transcript here: https://yourcaseworks.com/the-leverage-report/fall-2024-mtmp-recap-depo-provera-zantac-global-settlement/
In this episode of The Leverage Report, Dan Miner, CEO of Case Works, sits down with Devin Downey, co-founder and CEO of Blue Sky Legal, to discuss key challenges in mass tort case acquisition and the importance of creating strong partnerships between law firms and marketing agencies. Devin shares insights from his experience in the legal and advertising industries, touching on critical issues such as case attrition, lead generation quality, and the evolving dynamics of case development.
Key topics covered: - The impact of case fallout rates on mass tort firms and how to reduce them - Aligning marketing and case development teams to improve case outcomes - The importance of identity validation in intake and preventing fraudulent signups - Strategies to minimize dual representation and improve plaintiff communication - Evaluating marketing partners and lead generation in the mass tort space Whether you're a law firm looking to improve your intake process or a marketing partner aiming to align your efforts with law firm goals, this episode offers actionable insights and strategies. Get the full transcript here: https://yourcaseworks.com/the-leverage-report/mastering-mass-torts-true-cost-feedback-loops-vendor-relationships/ Learn more about Blue Sky Legal here: https://blueskylegal.com/ Get in touch with Case Works here: https://yourcaseworks.com/contact/
Welcome back to another episode of Tort Talk Thursday. We took last week off in preparation for our webinar on Tuesday, Oct 1. Thank you to all who joined - the recording will be available soon! In this episode, Joe Fantini from Rosen Injury Lawyers joins Susan again to discuss the latest developments in some of the biggest mass torts of 2024. On this week's episode of Tort Talk Thursday, we cover the following: 👉🏻 3rd NEC Trial in Missouri State Court + MDL news 👉🏻 Social Media Addiction Lawsuits Update 👉🏻 Zantac Cases (Delaware) - Upcoming Deadlines to be Aware Of 👉🏻 MTMP Next Week (Oct 8-10) Connect with Joe: https://www.linkedin.com/in/joseph-fantini/ Connect with Case Works: https://www.linkedin.com/company/your-case-works/ See the full transcript here: https://yourcaseworks.com/the-leverage-report/october-nec-social-media-addiction-zantac-lawsuits-news/
Joe Fantini joins us with the latest updates and insights in the mass tort space in another episode of Tort Talk Thursday! This week, Joe shares details regarding:
🟡 LFDealmakers in New York - are you looking at enough data to determine if your mass tort investments are paying off? Joe talks about the importance of data and how Case Works has really shown him important aspects of Rosen Injury Lawyer's data.
🟡 Toxic Baby Food: Why are attorneys so excited about this tort? The research and work has been in progress for 2+ years even though the MDL just formed in 2024. First trial already coming in early 2025.
🟡 Another Philadelphia Roundup trial coming soon. Though the tort has been ongoing for 10+ years, recent trials have shown great promise.
🟡 A lot of activity in the Zantac MDL this year. There is a briefing in October, among other actions happening in Delaware. Attorneys: now is a good time to obtain new cases! How to get in contact with Joe:
Email - jfantini@roseninjurylawyers.com
LinkedIn - https://www.linkedin.com/in/joseph-fantini/
Check out this week's sponsor, The Joel Company, here: https://joelcompany.com/
See the full video transcript here: https://yourcaseworks.com/the-leverage-report/sept-status-updates-toxic-baby-food-roundup-zantac-mdls/
🔔Don't forget to subscribe and stay updated on the latest Mass Tort news!
Join Susan and Joe this week to discuss the latest in mass tort news! 1. Toxic Baby Food: Discovery Requests + First Trial in CA State Court January 2025 2. Ozempic/Weight Loss: Quick Science Day Recap + 400 new Cases Filed 3. Suboxone: Defendant Document Production Upcoming; Important Hearing Set for Oct. 4th 4. J&J Agrees to Increase the Bankruptcy Package for Talc Claims by $1 billion
Connect with Joe: https://www.linkedin.com/in/joseph-fantini/
Connect with Case Works: https://www.linkedin.com/company/your-case-works/ What do you want to hear about next week? Let us know in the comments below. See full video with transcript here: https://yourcaseworks.com/the-leverage-report/sept-2024-jj-bankruptcy-suboxone-ozempic-cmc-recap-toxic-baby-food/
In this episode of Tort Talk Thursday, Joe Fantini from Rosen Injury Lawyers joins Susan again to discuss the latest developments in mass torts. On this week's episode of Tort Talk Thursday, Joe covers the following: 👉🏻 What to Expect from State Courts + MDL the rest of this year 👉🏻 What is Science Day and why is it important to the Ozempic MDL? 👉🏻 Status Updates on lawsuits against Bard and other manufacturers of Hernia Mesh Connect with Joe: https://www.linkedin.com/in/joseph-fantini/ Connect with Case Works: https://www.linkedin.com/company/your-case-works/ This episode is sponsored by Stratejic. Learn more about their services here: https://stratejicrelationships.com/ See the full transcript here: https://yourcaseworks.com/the-leverage-report/updates-nec-ozempic-hernia-mesh/
Our favorite mass tort guru, Joe Fantini, is back this week with updates on the latest developments in the industry. This week's Tort Talk Thursday covers: 👉🏻 Zantac Daubert ruling in Delaware. Joe provides guidance on next steps for those with Zantac cases 👉🏻Toxic baby food MDL case management conference recap 👉🏻 Non-MDL social media litigation ruling in Pennsylvania for 10-year old girl sets stage for the MDL 👉🏻 What to know about a few of the hottest legal conferences this Fall Our sponsor this week is LitPRO! Learn more about their services at: https://www.litprollc.com/ How to reach Joe: Visit https://roseninjurylawyers.com/team/joseph-fantini/ LinkedIn - https://www.linkedin.com/in/joseph-fantini/ How to reach Case Works: Visit https://yourcaseworks.com/contact/ LinkedIn - https://www.linkedin.com/company/your-case-works ❗️Don't forget to subscribe and turn on notifications to get the news first every Thursday! See the full video with transcript here: https://yourcaseworks.com/the-leverage-report/big-rulings-for-social-media-zantac-plus-baby-food-cmc-recap-upcoming-conferences/
In this episode of The Leverage Report, host Susan Barfield sits down with Tyler Schneider, Managing Partner at TorHoerman Law Firm, to discuss the groundbreaking $495M NEC verdict that recently made headlines. Tyler shares insights into the trial's key strategies, the emotional testimony that resonated with the jury, and the potential impact this case will have on future NEC litigation. From the complexities of working with NICU records to the pivotal moments that shaped the outcome, this conversation is a must-watch for anyone involved in mass tort litigation. Tune in to learn what this verdict means for the industry and how it could influence changes in feeding protocols for infants. Connect with Tyler: https://www.torhoermanlaw.com/team/tyler-schneider/ Connect with Case Works: https://yourcaseworks.com/contact/ See the full video and transcript here: https://yourcaseworks.com/the-leverage-report/495-million-nec-verdict-insights-with-tyler-schneider-of-torhoerman-law/
In this episode of Tort Talk Thursday, Joe Fantini from Rosen Injury Lawyers joins Susan again to discuss the latest developments in mass torts. On this week's episode of Tort Talk Thursday, Joe covers the following: 👉🏻 Ruling in the Third Circuit Court for Roundup 👉🏻 What to know about AFFF and Toxic Baby Food before the upcoming CMC Connect with Joe: / joseph-fantini Connect with Case Works: / your-case-works See the full transcript here: https://yourcaseworks.com/the-leverag... (opens in a new tab)
